Literature DB >> 27740622

Letting the breaks off MYCN.

Giovanni Perini1, Giorgio Milazzo1, Nisha Narayan2, Paul G Ekert2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27740622      PMCID： PMC5136483          DOI： 10.1038/cdd.2016.112

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  6 in total

1.  N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation.

Authors:  B A Malynn; I M de Alboran; R C O'Hagan; R Bronson; L Davidson; R A DePinho; F W Alt
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

2.  Targeted expression of MYCN causes neuroblastoma in transgenic mice.

Authors:  W A Weiss; K Aldape; G Mohapatra; B G Feuerstein; J M Bishop
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

Review 3.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

4.  Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.

Authors:  Ruediger Spitz; Barbara Hero; Karen Ernestus; Frank Berthold
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

5.  Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma.

Authors:  John T Powers; Kaloyan M Tsanov; Daniel S Pearson; Frederik Roels; Catherine S Spina; Richard Ebright; Marc Seligson; Yvanka de Soysa; Patrick Cahan; Jessica Theißen; Ho-Chou Tu; Areum Han; Kyle C Kurek; Grace S LaPier; Jihan K Osborne; Samantha J Ross; Marcella Cesana; James J Collins; Frank Berthold; George Q Daley
Journal:  Nature       Date:  2016-07-06       Impact factor: 49.962

6.  LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7.

Authors:  Blair B Madison; Qi Liu; Xue Zhong; Christopher M Hahn; Nan Lin; Matthew J Emmett; Ben Z Stanger; Ju-Seog Lee; Anil K Rustgi
Journal:  Genes Dev       Date:  2013-10-15       Impact factor: 11.361
  6 in total
  1 in total

Review 1.  Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs.

Authors:  Damiano Bartolucci; Andrea Pession; Patrizia Hrelia; Roberto Tonelli
Journal:  Pharmaceutics       Date:  2022-07-12       Impact factor: 6.525
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.